Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China · Delayed Price · Currency is CNY 18.54
+0.75 (4.22%)
Apr 28, 2026, 3:04 PM CST
SHE:000623 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 2,395 | 1,551 | 1,460 | 1,781 | 1,781 |
Depreciation & Amortization | 213.44 | 234.51 | 233.87 | 225.63 | 204.16 |
Other Amortization | 4.83 | 3.84 | 5.79 | 4.85 | 4.03 |
Loss (Gain) From Sale of Assets | -1.32 | 0.67 | -36.16 | -3.16 | 0.94 |
Asset Writedown & Restructuring Costs | 183.01 | 65.33 | 3.25 | 1.67 | 2.84 |
Loss (Gain) From Sale of Investments | -2,761 | -1,733 | -1,238 | -1,005 | -1,748 |
Provision & Write-off of Bad Debts | 0.28 | -6.23 | -4.64 | 11.62 | 5.15 |
Other Operating Activities | 92.21 | 101.08 | 184.7 | 188.3 | 143.12 |
Change in Accounts Receivable | 76.79 | 268.54 | -304.33 | -189.01 | 6.42 |
Change in Inventory | 67.49 | -113.74 | -16.93 | -301.23 | -59.61 |
Change in Accounts Payable | -24.78 | -254.64 | -97.31 | 443.58 | 31.83 |
Change in Other Net Operating Assets | -12.28 | -32.24 | -118.56 | -610.91 | - |
Operating Cash Flow | 272.26 | 59.48 | 68.06 | 423.86 | 324.85 |
Operating Cash Flow Growth | 357.70% | -12.60% | -83.94% | 30.48% | -16.79% |
Capital Expenditures | -128.45 | -273.98 | -419.52 | -270.97 | -313.3 |
Sale of Property, Plant & Equipment | 5.16 | 3.92 | 34.61 | 3.08 | 36.94 |
Cash Acquisitions | -0.23 | - | - | -2.13 | - |
Investment in Securities | -49.31 | -0.68 | 524.4 | -1,112 | -1,081 |
Other Investing Activities | 783.24 | 707.19 | 624.13 | 828.75 | 646.6 |
Investing Cash Flow | 610.41 | 436.44 | 763.62 | -553.21 | -710.4 |
Short-Term Debt Issued | - | - | 653.05 | 641.98 | 302.36 |
Long-Term Debt Issued | 1,055 | 3,571 | - | - | - |
Total Debt Issued | 1,055 | 3,571 | 653.05 | 641.98 | 302.36 |
Short-Term Debt Repaid | - | - | -651.69 | -374.93 | -342.38 |
Long-Term Debt Repaid | -1,119 | -3,319 | - | - | - |
Total Debt Repaid | -1,119 | -3,319 | -651.69 | -374.93 | -342.38 |
Net Debt Issued (Repaid) | -63.54 | 252.23 | 1.36 | 267.05 | -40.02 |
Repurchase of Common Stock | -120 | -300 | -150 | -170.04 | -100 |
Common Dividends Paid | -649.03 | -1,060 | -400.57 | -377.76 | -255.71 |
Other Financing Activities | -2.78 | -2.2 | - | 109.68 | 33.32 |
Financing Cash Flow | -835.35 | -1,110 | -549.21 | -171.07 | -362.4 |
Foreign Exchange Rate Adjustments | -0.15 | -0.25 | -0.72 | -4.12 | 1.73 |
Net Cash Flow | 47.17 | -614.29 | 281.75 | -304.55 | -746.23 |
Free Cash Flow | 143.81 | -214.5 | -351.46 | 152.89 | 11.54 |
Free Cash Flow Growth | - | - | - | 1224.31% | -92.92% |
Free Cash Flow Margin | 6.16% | -8.22% | -10.19% | 5.33% | 0.50% |
Free Cash Flow Per Share | 0.12 | -0.18 | -0.27 | 0.12 | 0.01 |
Cash Income Tax Paid | 223.13 | 218.53 | 304.37 | 205.93 | 207.45 |
Levered Free Cash Flow | 142.92 | -254.86 | -526.06 | -2.86 | -139.08 |
Unlevered Free Cash Flow | 175.58 | -197.3 | -435.84 | 86.51 | -57.53 |
Change in Working Capital | 145.85 | -158.33 | -540.95 | -781.03 | -67.95 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.